Device Trial Radar · NCT02378844
A Randomized, Sham-controlled Study of gammaCore ® (nVNS) for Prevention of Episodic Migraine
Last checked: Nov 19, 2026Latest source record: Aug 19, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
477
Actual
Start
Jun 2015
Primary completion
Feb 1, 2018
Study completion Aug 29, 2018
Sponsor
- Lead sponsor
- ElectroCore INCNot on our public-company list
- Sponsor type
- Industry
- First posted
- Mar 4, 2015
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Prevention
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A prospective, double-blind, randomized, sham-controlled, multicentre investigation.
Conditions
- Migraine
Interventions
gammaCore®-RDevice
Subjects will be instructed to treat three times per day, 2 consecutive bilateral stimulations, upon waking, six to eight hours following the first daily treatment, and six to eight hours following the second daily treatment (one stimulation on the right side immediately followed by a second stimulation on the left side).
gammaCore®-R ShamDevice
Subjects will be instructed to treat three times per day, 2 consecutive bilateral stimulations, upon waking, six to eight hours following the first daily treatment, and six to eight hours following the second daily treatment (one stimulation on the right side immediately followed by a second stimulation on the left side).
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in the Number of Migraine DaysTime frame: last 4 weeks of the randomized/controlled period compared to the subject's own 4-week run-in period.
Locations
22 sites in 8 countries. Site status is shown where the registry gives one.
Neurology Department, University of Liège
Liège, Belgium
Danish Headache Center
Glostrup Municipality, Denmark
Neurologische Klinik und Poliklinik, Charité Campus Mitte
Berlin, Germany
19 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.